From Social Security to tourism, government shutdown would affect public

By Laurel Adams

A government shutdown looks increasingly likely as Democrats and Republicans fail to reach an agreement on the federal budget. A report by t

Related to this story

Navy’s small ship program criticized by GAO

By Julie Vorman

Fact Check: The (high) price of a shutdown

By Keith Epstein

DOD struggles with medical e-records system

By Laurel Adams

DOE accused of violating federal hiring rules

By Julie Vorman

Excerpts from this story referencing "National Institute of Health":

"… l research trials and hot line calls about diseases went unanswered at the National Institute of Health. Toxic waste cleanup at 609 sites stopped and 2,400 Superfund workers were …"

Capitol Hill stem-cell backers received health industry dollars

By M. Asif Ismail and Christine Morente

WASHINGTON, August 30, 2001 — U.S. representatives and senators who strongly pushed for federally subsidized embryonic stem cell research ha

Related to this story

Issue divides Bush advisers

By M. Asif Ismail

Embryo research: profit vs ethics?

By Shaun Taylor-Corbett

Lobbying, old-time politics block legislation on human cloning

By M. Asif Ismail

Globalizing research

By Alexander Cohen

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Related to this story

Heart testing bill signed by Perry required unnecessary tests, critics charge

By Rochelle Sharpe

Drug makers' dime funds Congressional travel

By Robert Brodsky

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

Checkbook politics

By Victoria Kreha

Advertisement

NIH urged to create single website showing grantees’ funding

Dr. Charles Nemeroff’s name is synonymous with what can go wrong when scientists who receive funding from the National Institutes of Health

Related to this story

Six digital commandments for new consumer agency to succeed

By Michael Hudson

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Related to this story

Drug industry influence timeline

By The Center for Public Integrity

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

FDA: A shell of its former self

By M. Asif Ismail

Closing in on human cloning

By M. Asif Ismail and Agustín Armendariz

The federal government is funding research in primate cloning technology. Why?

Related to this story

Lobbying, old-time politics block legislation on human cloning

By M. Asif Ismail

Globalizing research

By Alexander Cohen

Special report: Dim chance for global cloning ban

By M. Asif Ismail

Where scientists call the shots

By Tamra Traubmann

Advertisement

Embryo research: profit vs ethics?

By Shaun Taylor-Corbett

Corporations team up with patients' rights groups to overpower opposition to research that destroys embryos, but could save lives

Related to this story

Regulating cloning

By M. Asif Ismail

Issue divides Bush advisers

By M. Asif Ismail

Globalizing research

By Alexander Cohen

Lobbying, old-time politics block legislation on human cloning

By M. Asif Ismail

From 'God's handwriting' to corporate profits

By Nathaniel Heller

Genome companies and their lawyers and lobbyists have locked up federal policy on human gene patenting with little public discussion

Related to this story

Massive backlog at patent office

By The Center for Public Integrity

State utility commissions fail transparency test

By John Dunbar and Leah Rush

Favorable logistics

By Claudio Julio Tognolli

Six Questions for Kendra Barkoff